Copyright © 2000 by the European Society of Cardiology.
A national survey of heart failure in French hospitals
revised June 15, 1999; accepted June 23, 1999
Abstract
Rationale The epidemiology of heart failure and patient management procedures may vary from one country to another. This study was designed to analyse the spectrum of patients hospitalized in France for heart failure.
Patients and Methods A registry involving 120 departments (cardiology, general medicine and geriatrics) and 1058 patients.
Results The patients' median age was 76 years, and the male/female ratio was 55/45. Echocardiography was performed in 77% of the cases: the left ventricular ejection fraction was <30% in 22%, between 30 and 40% in 25% and greater than 40% in 53%. Angiotensin-converting enzyme (ACE) inhibitors were prescribed to, respectively, 78% and 63% of patients with ejection fractions above and below 40%.
Conclusion In France, patients hospitalized for heart failure tend to be old and are often women; about one in two have relatively preserved left ventricular systolic function. ACE inhibitor prescription seems to be more frequent than currently reported. This survey confirms the clear gap between the populations in clinical trials and those in routine clinical practice.
Key Words: Heart failure, epidemiology, hospitalization, ejection fraction, age, ACE inhibitors
f1 Correspondence: Alain Cohen-Solal, Service de Cardiologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92110, Clichy, France.
References
- Ho K, Pinsky J, Kannel W, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22:6–13A[Web of Science][Medline]
- McMurray J, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ. 1993;285:99–110
- Circulation. 1995;92:2764–2784
[Free Full Text] - Eur Heart J. 1997;18:736–753
[Free Full Text] - Cleland J. ACE inhibitors for the prevention and treatment of heart failure: why are they ‘under-used’? J Hum Hypertens. 1995;9:435–442[Web of Science][Medline]
- Cowie MR, Mosterd A, Wood DA. The epidemiology of heart failure. Eur Heart J. 1997;18:208–225
[Free Full Text] - Lindenfeld J, Krausesteinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol. 1997;30:1417–1419[Abstract]
- Senni M, Tribouilloy C, Rodeheffer R. Congestive heart failure in the community: a study of all incident cases in Olmsted county, Minnesota, in 1991. Circulation. 1998;98:2282–2289
[Abstract/Free Full Text] - Zannad F, Briançon S, Juillières Y. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol. 1999;33:734–742
[Abstract/Free Full Text] - McKee P, Castelli W, Namara W. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–1446[Web of Science][Medline]
- Eur Heart J. 1997;18:1457–1464
[Abstract/Free Full Text] - Davie A, Francis C, Love M. Value of the electrocardiogram in identifying heart failure due to left ventricular dysfunction. Br Med J. 1996;312:222
[Free Full Text] - Opasich C. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol. 1996;78:354–357[CrossRef][Web of Science][Medline]
- Chin M, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 1997;87:643–648
[Abstract/Free Full Text] - Wheeldon N, MacDonald T, Flucker C, McKendrick A, McDevitt D, Struthers A. Echocardiography in chronic heart failure in the community. Q J Med. 1993;86:17–23[Web of Science][Medline]
- Francis C, Caruana L, Kearney P. Open access echocardiography in management of heart failure in the community. Br Med J. 1995;310:634–636
[Abstract/Free Full Text] - Clarke K, Gray D, Hampton J. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994;71:584–587
[Abstract/Free Full Text] - Cowie MR, Struthers AD, Wood DA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1349–1353[CrossRef][Web of Science][Medline]
- Aronow W, Ahn C, Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest. 1998;113:867–869
[Abstract/Free Full Text] - Hillis GS, Trent RJ, Winton P, MacLeod AM, Jennings KP. Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: Are we ignoring the evidence? Qjm-Mon J Assoc Physician. 1996;89:145–150
[Abstract/Free Full Text] - Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996;77:832–838[CrossRef][Web of Science][Medline]
- Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460–2464
[Abstract/Free Full Text] - Granger C, Ertl G, Kuch J. A randomized trial evaluating tolerability of candesartan cilexitil for patients with congestive heart failure and intolerance to angiotensin converting enzyme inhibitors (Abstr). Eur Heart J. 1998;19:113
- Krumholz HM, Vaccarino V, Ellerbeck EF. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons
65 years of age. Am J Cardiol. 1997;79:581–586[CrossRef][Web of Science][Medline]
- Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med. 1997;157:2242–2247
[Abstract/Free Full Text] - Brilla C, Janicki J, Weber K. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771–1779
[Abstract/Free Full Text] - Friedrich SP, Lorell BH, Rousseau MF. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation. 1994;90:2761–2771
[Abstract/Free Full Text] - Philbin EF, Rocco TA. The utility of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J. 1997;134:188–195[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Komajda, O. Hanon, M. Hochadel, J. L. Lopez-Sendon, F. Follath, P. Ponikowski, V.-P. Harjola, H. Drexler, K. Dickstein, L. Tavazzi, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur. Heart J., February 2, 2009; 30(4): 478 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. de Groote, R. Isnard, P. Clerson, G. Jondeau, M. Galinier, P. Assyag, N. Demil, A. Ducardonnet, J.-F. Thebaut, and M. Komajda Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme Eur J Heart Fail, January 1, 2009; 11(1): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Remme, J. J.V. McMurray, F.D. R. Hobbs, A. Cohen-Solal, J. Lopez-Sendon, A. Boccanelli, F. Zannad, B. Rauch, K. Keukelaar, C. Macarie, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians Eur. Heart J., July 2, 2008; 29(14): 1739 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Grewal, R. McKelvie, E. Lonn, P. Tait, J. Carlsson, M. Gianni, C. Jarnert, and H. Persson BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction Eur J Heart Fail, March 1, 2008; 10(3): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Berry, M Brett, K Stevenson, J J V McMurray, and J Norrie Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure Heart, March 1, 2008; 94(3): 296 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. de Groote, R. Isnard, P. Assyag, P. Clerson, A. Ducardonnet, M. Galinier, G. Jondeau, I. Leurs, J.-F. Thebaut, and M. Komajda Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey Eur J Heart Fail, December 1, 2007; 9(12): 1205 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Komajda, O. Hanon, M. Hochadel, F. Follath, K. Swedberg, A. Gitt, and J. G.F. Cleland Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I Eur. Heart J., June 1, 2007; 28(11): 1310 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lainscak, J. G.F. Cleland, M. J. Lenzen, F. Follath, M. Komajda, and K. Swedberg International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey Eur J Heart Fail, March 1, 2007; 9(3): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Persson, E. Lonn, M. Edner, L. Baruch, C. C. Lang, J. J. Morton, J. Ostergren, R. S. McKelvie, and for the Investigators of the CHARM Echocardiograph Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence: Results From the CHARM Echocardiographic Substudy-CHARMES J. Am. Coll. Cardiol., February 13, 2007; 49(6): 687 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N M Hawkins, D Wang, J J V McMurray, M A Pfeffer, K Swedberg, C B Granger, S Yusuf, S J Pocock, J Ostergren, E L Michelson, et al. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme Heart, January 1, 2007; 93(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Coste, P. Jourdain, and J. Pouchot A Gray Zone Assigned to Inconclusive Results of Quantitative Diagnostic Tests: Application to the Use of Brain Natriuretic Peptide for Diagnosis of Heart Failure in Acute Dyspneic Patients Clin. Chem., December 1, 2006; 52(12): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zannad, A. Mebazaa, Y. Juilliere, A. Cohen-Solal, L. Guize, F. Alla, P. Rouge, P. Blin, M.-H. Barlet, L. Paolozzi, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study Eur J Heart Fail, November 1, 2006; 8(7): 697 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm, and W. Herrmann A review of homocysteine and heart failure Eur J Heart Fail, October 1, 2006; 8(6): 571 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Passantino, R. Lagioia, F. Mastropasqua, and D. Scrutinio Short-Term Change in Distance Walked in 6 Min Is an Indicator of Outcome in Patients With Chronic Heart Failure in Clinical Practice J. Am. Coll. Cardiol., July 4, 2006; 48(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Kurtz, Y. Gerber, S. A. Weston, M. M. Redfield, S. J. Jacobsen, and V. L. Roger Use of Ejection Fraction Tests and Coronary Angiography in Patients With Heart Failure Mayo Clin. Proc., July 1, 2006; 81(7): 906 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Lenzen, E. Boersma, W. J.M. Scholte op Reimer, A. H.M.M. Balk, M. Komajda, K. Swedberg, F. Follath, M. Jimenez-Navarro, M. L. Simoons, and J. G.F. Cleland Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur. Heart J., December 2, 2005; 26(24): 2706 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Squire Managing patients with heart failure: the reality of clinical practice Eur. Heart J., December 2, 2005; 26(24): 2611 - 2613. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmed Association of Diastolic Dysfunction and Outcomes in Ambulatory Older Adults With Chronic Heart Failure J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2005; 60(10): 1339 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 GESICA Investigators Randomised trial of telephone intervention in chronic heart failure: DIAL trial BMJ, August 20, 2005; 331(7514): 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Berry, K Hogg, J Norrie, K Stevenson, M Brett, and J McMurray Heart failure with preserved left ventricular systolic function: a hospital cohort study Heart, July 1, 2005; 91(7): 907 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zannad Acute heart failure syndromes: the 'Cinderella' of heart failure research Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B8 - B12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bendjelid, N. Schutz, P. M. Suter, G. Fournier, D. Jacques, S. Fareh, and J.-A Romand Does Continuous Positive Airway Pressure by Face Mask Improve Patients With Acute Cardiogenic Pulmonary Edema Due to Left Ventricular Diastolic Dysfunction? Chest, March 1, 2005; 127(3): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roman-Sanchez, P. Conthe, J. Garcia-Alegria, J. Forteza-Rey, M. Montero, C. Montoto, and for the Heart Failure Working Group of the Spanish Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey QJM, February 1, 2005; 98(2): 127 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure Eur. Heart J., October 1, 2004; 25(19): 1711 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Opasich, S. De Feo, G.A. Ambrosio, P. Bellis, A. Di Lenarda, G. Di Tano, D. Fico, L. Gonzini, R. Lavecchia, C. Tomasi, et al. The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists Eur J Heart Fail, October 1, 2004; 6(6): 769 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Denis, C. de Kerguennec, J. Bernuau, F. Beauvais, and A. C. Solal Acute hypoxic hepatitis ('liver shock'): still a frequently overlooked cardiological diagnosis Eur J Heart Fail, August 1, 2004; 6(5): 561 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.J Lenzen, W.J.M Scholte op Reimer, E Boersma, P.J.M.J Vantrimpont, F Follath, K Swedberg, J Cleland, and M Komajda Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur. Heart J., July 2, 2004; 25(14): 1214 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen, and DIAMOND Study Group Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J. Am. Coll. Cardiol., March 3, 2004; 43(5): 771 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Thomas, K. F. Fox, A. J.S. Coats, and G. C. Sutton The epidemiological enigma of heart failure with preserved systolic function Eur J Heart Fail, March 1, 2004; 6(2): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tendera The epidemiology of heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S2 - S6. [Abstract] [PDF]
|
|
|
|
|
|
K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis J. Am. Coll. Cardiol., February 4, 2004; 43(3): 317 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Johnson, Y. Jin, H. Quan, and B. Cujec Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1438 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. De Geest, L. Scheurweghs, I. Reynders, W. Pelemans, W. Droogne, J. Van Cleemput, M. Leventhal, and J. Vanhaecke Differences in psychosocial and behavioral profiles between heart failure patients admitted to cardiology and geriatric wards Eur J Heart Fail, August 1, 2003; 5(4): 557 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McMurray, J. Ostergren, M. Pfeffer, K. Swedberg, C. Granger, S. Yusuf, P. Held, E. Michelson, B. Olofsson, and On behalf of the CHARM committees and investigator Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme Eur J Heart Fail, June 1, 2003; 5(3): 261 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, B. Brendorp, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur. Heart J., May 1, 2003; 24(9): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Study Group of Diagnosis of the Working Group, M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, A. Cohen-Solal, R. Dietz, A. Gavazzi, W.H. Van Gilst, et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe: Part 2: treatment Eur. Heart J., March 1, 2003; 24(5): 464 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S D Hutcheon, N D Gillespie, I K Crombie, A D Struthers, and M E T McMurdo Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial Heart, October 1, 2002; 88(4): 373 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Heiat, C. P. Gross, and H. M. Krumholz Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials Arch Intern Med, August 12, 2002; 162(15): 1682 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cohen-Solal Diastolic heart failure: myth or reality? Eur J Heart Fail, August 1, 2002; 4(4): 395 - 400. [Full Text] [PDF]
|
|
|
|
|
|
P. Banerjee, T. Banerjee, A. Khand, A. L. Clark, and J. G. F. Cleland Diastolic heart failure: neglected or misdiagnosed? J. Am. Coll. Cardiol., January 2, 2002; 39(1): 138 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Komajda, J.B. Bouhour, P. Amouyel, F. Delahaye, E. Vicaut, I. Croce, E. Rougemond, F. Vuittenez, and E. Leutenegger Ambulatory heart failure management in private practice in France Eur J Heart Fail, August 1, 2001; 3(4): 503 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bellotti, L.P. Badano, N. Acquarone, R. Griffo, G. Lo Pinto, A.P. Maggioni, C. Mattiauda, G. Menardo, and P. Mombelloni Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study Eur. Heart J., April 1, 2001; 22(7): 596 - 604. [Abstract] [PDF]
|
|
|
|
|
|
A. M Tonkin GENERAL CARDIOLOGY: Evaluation of large scale clinical trials and their application to usual practice Heart, December 1, 2000; 84(6): 679 - 684. [Full Text]
|
|
|
|
|
|
J. McMurray Heart failure: we need more trials in typical patients Eur. Heart J., May 1, 2000; 21(9): 699 - 700. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||